Lyra Therapeutics, Inc. (LYRA) Net income 2019–2025
Lyra Therapeutics, Inc. (LYRA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$28.9MFY2025 · since FY2019: -$16.3M → -$28.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$28.9M | +69.0% |
| FY2024 | -$93.4M | -49.1% |
| FY2023 | -$62.7M | -13.4% |
| FY2022 | -$55.3M | -27.0% |
| FY2021 | -$43.5M | -96.7% |
| FY2020 | -$22.1M | -35.7% |
| FY2019 | -$16.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice